| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5697574 | Cancer Treatment Reviews | 2017 | 32 Pages |
Abstract
Treatment with targeted agents in cancer patients is correlated with a significant increase in the risk of cardiotoxicity. Frequent clinical monitoring should be emphasized when using these and newer biological agents.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Matteo Santoni, Federico Guerra, Alessandro Conti, Alessandra Lucarelli, Silvia Rinaldi, Laura Belvederesi, Alessandro Capucci, Rossana Berardi,